ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta (OI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00131469
Recruitment Status : Completed
First Posted : August 18, 2005
Last Update Posted : November 1, 2013
Sponsor:
Collaborators:
Eli Lilly and Company
Osteogenesis Imperfecta Foundation
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
Information provided by (Responsible Party):
Eric Orwoll, MD, Oregon Health and Science University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2011
  Actual Study Completion Date : January 2011